🇺🇸 LGND — Ligand Pharmaceuticals Incorporated

Salud Compra fuerte
← Volver

Precio actual

306,20 USD

Máx. histórico

322,75

7 días

Split 1603:1000 del 02/11/2022

Caída desde máximo

-5,13%

Rango 52 semanas

175,89 – 326,63

Variación hoy

+2,41%

Cierre anterior

299,00

Rango de hoy

297,84 – 308,26

Volumen hoy

130.173

Peor caída histórica

-93,34%

06/03/2000 → 19/11/2008

Recuperado en 2694 días

Volatilidad anualizada ⓘ

59,76%

Información
Nombre completo
Ligand Pharmaceuticals Incorporated
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
47
PER ⓘ
122,97 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
351,33 USD (puede no estar actualizado)
Primera cotización
18/11/1992
Precio actualizado
hace 17 horas
Sobre la empresa

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.

Dividendos repartidos Total últimos 12 meses: 0,0000 USD · Yield: 0,00%
Fecha de pago Importe por participación
03/04/2007 9,3575 USD
Splits Registrados en el histórico de precios
Fecha Ratio
02/11/2022 1603:1000
19/11/2010 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
09/08/2000 44,21 44,45 40,70 40,70 -5,43% 8,47% 30.110
08/08/2000 42,81 44,92 42,58 43,04 +0,00% 5,46% 49.346
07/08/2000 39,54 43,28 39,30 43,04 +5,75% 10,06% 63.185
04/08/2000 42,11 42,34 37,66 40,70 +0,00% 11,11% 61.716
03/08/2000 40,70 42,58 40,70 40,70 -1,14% 4,60% 43.521
02/08/2000 43,51 44,45 40,70 41,17 -4,86% 8,60% 35.934
01/08/2000 38,37 44,97 37,90 43,28 +15,62% 18,45% 123.752
31/07/2000 39,77 40,00 37,43 37,43 -6,98% 6,47% 104.916
28/07/2000 40,47 41,87 40,24 40,24 +1,18% 4,05% 43.415
27/07/2000 41,87 43,51 39,77 39,77 -5,56% 8,94% 40.636
26/07/2000 43,98 44,92 42,11 42,11 -4,76% 6,38% 58.055
25/07/2000 44,45 45,15 43,98 44,21 -0,53% 2,63% 32.541
24/07/2000 45,85 46,79 43,98 44,45 -4,04% 6,12% 36.335
21/07/2000 46,55 47,26 45,85 46,32 -0,50% 3,02% 48.758
20/07/2000 44,92 46,79 44,45 46,55 +4,74% 5,21% 65.937
19/07/2000 45,85 46,79 43,98 44,45 -4,04% 6,12% 48.010
18/07/2000 45,38 46,79 44,92 46,32 +4,21% 4,12% 49.266
17/07/2000 45,15 46,79 44,45 44,45 -2,56% 5,18% 68.822
14/07/2000 45,62 46,09 44,45 45,62 -0,51% 3,59% 55.865
13/07/2000 46,79 48,42 45,15 45,85 -2,00% 7,00% 75.448
12/07/2000 47,96 47,96 45,85 46,79 -1,96% 4,39% 41.144
11/07/2000 46,32 49,59 46,09 47,72 -1,92% 7,58% 67.673
10/07/2000 47,02 48,66 45,38 48,66 -1,89% 6,97% 92.279
07/07/2000 50,06 51,47 48,89 49,59 -0,93% 5,14% 55.090
06/07/2000 48,66 50,30 47,96 50,06 +2,88% 4,81% 45.365
05/07/2000 49,59 49,83 47,49 48,66 +0,00% 4,72% 35.239
03/07/2000 49,83 49,83 46,79 48,66 -1,42% 6,10% 33.957
30/06/2000 50,06 50,53 47,72 49,36 +0,96% 5,61% 58.403
29/06/2000 51,23 51,70 46,55 48,89 +0,00% 10,05% 111.970
28/06/2000 46,55 49,13 45,85 48,89 +3,98% 7,04% 33.209